IQVIA Holdings | IQV - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Accenture USD 3.15B 693.17M 2026-03
Agilent USD 364M 78M 2025-12
Bruker USD 117M 95.1M 2026-06
Cardinal Health USD 782M 390M 2026-06
Celltrion KRW 11.84B 1.34B 2026-03
Charles River Laboratories USD -29.94M 264.16M 2026-03
Cigna USD 2.27B 453M 2026-03
Cognizant Technology Solutions USD 15.07B 53.04M 2026-03
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
CVS Health USD 3.94B 2.58B 2026-03
Danaher USD 1.08B 157M 2026-06
Dentsply International USD -42M 105M 2026-03
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Divis Laboratories Ltd INR 11.8B 2.17B 2026-06
Elevance Health USD 2.16B 146M 2026-06
Humana USD 1.6B 2.61B 2026-03
IBM USD 2.13B 2.01B 2026-03
Illumina USD 260M 103M 2026-06
Infosys INR 107.47B 15.6B 2026-03
Kangmei Pharma CNY -14.01M 16.08M 2026-03
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Laboratory Of America USD 8.61B 121.8M 2026-06
McKesson USD 2.12B 495M 2026-03
Mettler Toledo International USD 209.66M 119.42M 2026-03
Organigram Holdings CAD -921K 40.8M 2026-03
Pharma Mar EUR -993K 2.59M 2026-06
Publicis EUR 549M 487M 2025-06
Qiagen NV USD 157.9M 72.08M 2026-06
Quest Diagnostics USD 334M 4M 2026-03
Revvity USD 187.24M 137.25M 2026-06
Sartorius EUR 127M 30.8M 2026-06
Thermo Fisher Scientific USD 1.73B 389M 2026-03
Tilray USD -39.96M 39.19M 2025-09
UnitedHealth USD 7.36B 600M 2026-06
Veeva Systems USD 469.79M 152.26M 2026-03
Veradigm USD 35.3M 13.95M 2022-09
Waters USD 356M 444M 2026-06
Zealand Pharma A/S -394M 12.5M 2026-03
Zz Pientze Pharmaceu CNY 876.07M 352.96M 2026-03